2022 Korean VC Financings Led By Mid-Stage Bioventures
'Focus And Select' Strategy
Executive Summary
Amid a generally harsh environment, venture capital investors in South Korea appeared to take a more selective approach in 2022, with more established and financially stable domestic bioventures the biggest beneficiaries.